Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 1
Submit an article Journal homepage
359
Views
110
CrossRef citations to date
0
Altmetric
Research Article

Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries

L. Annemans Health Economics and Disease Management (HEDM), Brusselsesteenweg 91, 1860 Meise, Belgium
,
K. Moeremans Department of Public Health, Ghent University, Ghent, Belgium
,
M. Lamotte Health Economics and Disease Management (HEDM), Brusselsesteenweg 91, 1860 Meise, Belgium
,
J. Garcia Conde University Clinic Hospital, University of Valencia, Valencia, Spain
,
Henk van den Berg Emma Children Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands
,
H. Myint Royal Bournemouth Hospital, Bournemouth Dorset, UK
,
R. Pieters Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands
&
A. Uyttebroeck University Hospital Gasthuisberg, Leuven, Belgium
 show all
Pages 77-83 | Published online: 01 Jul 2009

  • Wolf G., Hegewish-Becker, S., Hossfeld, D. K. and Stahl, R. A. K. (1999) "Hyperuricemia and renal insufficiency associated with malignant disease: urate oxidase as an efficient therapy?", American Journal of Kidney Diseases 34(5). E20.
  • Van Der Klooster, J. M., Van Der Wiel, H. E., Van Saase, J.L.C.M. and Grootendorst, A. F. (2000) "Asystole during combination chemotherapy for non-Hodgkin's lymphome: the acute tumor lysis syndrome". Netherlands Journal of Medicine 56. 147-152.
  • Tomera, J. F. (1999) " Acute tumor lysis syndrome: considerations of cause and prevention". Drugs of Today 35(2), 79-87.
  • Jones, D. P., Mahmoud, H. and Chesney, R. W. (1995) " Tumor lysis syndrome: pathogenesis and management". Pediatric Nephrology 9, 206-212.
  • Seidemann, K., Meyer, U., Jansen, P., Yakisan, E., Rieske, K., FU+00Fchrer, M., Kremens, B., Schrappe, M. and Reiter, A. (1998) "Impaired renal function and tumor lysis syndrome in pediatric patients with Non-Hodgkin's Lymphoma and B-ALL. Observations from the BFM-trials", Klinische Padiatrie 210(4), 279-284.
  • Altman, A. (2001) "Acute tumor lysis syndrime". Seminars in Oncology 28(Suppl. 5). 3-8.
  • Hande, K. R. and Garrow, G. C. (1993) "Acute tumor lysis syndrome in patients with high grade non-Hodgkin's lymphome". American Journal of Medicine 94(2), 133-139.
  • Kedar, A., Grow, W. and Neiberger, R. E. (1995) "Clinical versus laboratory tumor lysis syndrome in children with acute leukaemia", Pediatric Hematology and Oncology 12(2), 129-134.
  • Sallan, S. (2001) "Management of acute tumor lysis syndrome", Seminars in Oncology 28(Suppl. 5), 9-12.
  • Farber, M. S. (2001) "Pharmacoeconomic considerations in the management of acute tumour lysis syndrome", Seminars in Oncology 28(2 Suppl. 5), 19-22.
  • Gold, M. R., Siegel, J. E., Russell, L. B., Weinstein, M. C., eds. (1996) Cost-effectiveness in Health and Medicine (Oxford University Press, Oxford).
  • Lascombes, F., Sommelet, D., Gebhard, F., Leverger, G., Schaison, G., Pinkerton, R., Bosly, A. and Boos, J. (1998) "High efficiency of recombinant urate oxidase in the prevention of renal failure related to tumor lysis syndrome", Blood 92(10 Suppl. 1)-237B. Abstract 4019.
  • Shiell, A. and Law, M. G. (2001) "The cost of hepatitis C and the cost-effectiveness of its prevention", Health Policy 58(2). 121-131.
  • Van Gaal, L. F., De Herthogh, R., Smekens, P. and Annemans, L. (2000) "De totale kosten van ge-zondheidszorg bij type-2 diabetes patiënten in Belgie: resultaten van de CODE-2 studie", Tijdschrift voor Geneeskunde, In press.
  • Lamotte, M., Annemans, L., Lefever, A., Nechelput, M. and Masure, J. (2002) "A health economic model to assess the long-term effects and cost-effectiveness of orlistal in obese type 2 diabetic patients", Diabetes Care 25(2), 303-308.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.